Burning Rock Biotech Ltd
BNR- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001792267
No open-market purchases or sales by Burning Rock Biotech Ltd insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $14.7M in total; no superinvestor holds it.
Holders of 5% or more of BNR
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Burning Rock Biotech Ltd, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Kynam Capital Management, LP | 13G/A | 13.97%0 shares | +2.96 ppfrom 11.01% | Nov 14, 20252 filings | May 15, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Burning Rock Biotech Ltd, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 15, 20264:01 PM ET | Kynam Capital Management, LPand 2 others | 13G/A | 13.97%0 shares | +2.96 ppfrom 11.01% | Mar 31, 2026 | SEC |
| May 13, 20265:12 PM ET | CRCM LPand 3 others | 13G/A | 3.20%282.1K shares | −2.18 ppfrom 5.38%Below 5% | Mar 31, 2026 | SEC |
| Dec 19, 20256:00 PM ET | CRCM LPand 3 others | 13G | 5.38%486.4K shares | New | Dec 16, 2025 | SEC |
| Nov 14, 202512:37 PM ET | Kynam Capital Management, LPand 2 others | 13G/A | 11.01%994.9K shares | – | Sep 30, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Burning Rock Biotech Ltd shares.
No Form 144 notices for Burning Rock Biotech Ltd are on file.